RHHBY

Roche (QX) News

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Small Cap Pro
Monthly Subscription
for only
$49.05
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
VAT not included
Company Name Stock Ticker Symbol Market Type
Roche Holdings Ltd AG (QX) RHHBY OTCMarkets Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.67 1.39% 48.92 16:01:14
Open Price Low Price High Price Close Price Prev Close
48.39 48.37 48.93 48.25
more quote information »

Recent News

Date Time Source Heading
10/15/202113:20DJNGenentech: FDA Approves Tecentriq as Adjuvant Treatment for..
10/12/202113:23SEEKSanofi expects constraints for Kevzara supplies until early..
10/12/202108:45NNWReal-World Data, Point-of-Care Testing Reshaping Healthcare,..
10/12/202107:23DJNCombiGene Shares More Than Double on $328.5 Million Epilepsy..
10/08/202112:31DJNRoche's Gantenerumab Gets FDA Breakthrough Therapy..
10/07/202116:31SEEKMid-stage data from two cancer candidate disappoints;..
10/04/202109:00SEEKSurface Oncology plans to initiate mid-stage SRF388..
10/01/202113:18SEEKFDA accepts Coherus BioSciences' BLA filing for Lucentis..
9/30/202101:52DJNRoche: Phase 2/3 Trial of Covid-19 Treatment Ronapreve Met..
9/20/202108:21DJNBiogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
9/20/202107:56SEEKFDA approves Samsung Bioepis and Biogen’s Byooviz
9/15/202108:00SEEKBiogen to start spinal muscular atrophy trial for higher..
9/09/202101:54DJNRoche to Acquire Biotech Company TIB Molbiol Group
9/07/202113:32DJNAdaptimmune Therapeutics Shares Rise 24% After Genentech..
9/07/202108:16DJNAdaptimmune Therapeutics in Licensing Deal With Genentech
9/01/202109:30TRMNAC Immune Jumps 16.3% on Partial Success in Alzheimer’s Drug..
8/31/202110:55DJNAC Immune Shares Rally on Renewed Hope for Semorinemab in..
8/31/202108:33DJNAC Immune: Semorinemab Meets Co-Primary Endpoint in..
8/27/202112:35DJNRoche Withdraws Accelerated Approval for Tecentriq Cancer..
8/09/202107:54SEEKGenentech's Polivy meets primary endpoint as first-line..
8/09/202102:58DJNRoche's Phase 3 Study on Polivy With Chemotherapy Regimen..
8/05/202113:22DJNSyros Pharmaceuticals Shares Rise After Supply Agreement..
8/05/202107:57DJNSyros Pharmaceuticals in Clinical Supply Agreement With..
8/03/202105:11SEEKFDA grants priority review to Genentech’s Tecentriq in lung..
7/22/202107:13SEEKRoche tops H1 consensus; Analysts expect drop in..
7/22/202105:26SEEKRoche to discuss Alzheimer's candidate with FDA
7/22/202104:24SEEKRoche Holding EPS beats by CHF0.38, beats on revenue
7/22/202102:50DJNRoche 1st Half Net Profit Fell Despite Higher Sales; Backs..
7/22/202102:03DJNRoche 1st Half Net Profit Fell Despite Higher Sales; Backs..
7/21/202104:04TRMNRoche Earnings Preview: Here’s What to Look For
7/20/202106:20SEEKJapan approves Regeneron/Roche's antibody cocktail REGEN-COV..
7/20/202101:45DJNRoche's Ronapreve Treatment for Covid-19 Approved by Japan
7/19/202121:58DJNChugai Pharmaceutical Obtains Approval for Covid Antibody..
7/15/202110:38SEEKFDA, Alzheimer's stakeholders look at expediting..
7/01/202109:27SEEKRoche to seek early FDA approval for Alzheimer’s therapy:..
6/30/202109:00SEEKAtea, Roche COVID drug successful in phase 2; Atea shares..
6/30/202107:50DJNAtea Pharma Reports Encouraging Results From Study of..
6/28/202108:21SEEKTeva to partner with Bioeq to market Lucentis biosimilar
6/28/202106:57SEEKExelixis drops 6% on disappointing cabozantinib combo data..
6/28/202103:06SEEKRoche’s Enspryng OK'd in Europe as first at-home treatment..
6/25/202115:21SEEKVividion Therapuetics files for $100M IPO
6/25/202102:56DJNRoche: Actemra/RoActemra Gets FDA Emergency-Use..
6/25/202100:35SEEKRoche's Actemra wins FDA emergency use nod for hospitalized..
6/24/202114:11DJN4D Molecular Shares Hit 52-Week Low After Roche Ends..
6/24/202110:34SEEK4D Molecular Therapeutics falls as Roche ends pact for..
6/24/202109:33DJN4D Molecular Therapeutics Gets Termination Notice From Roche
6/24/202106:48DJNRoche Eye-Treatment Application Accepted
6/24/202101:37SEEKFDA accepts Roche's application for Port Delivery System..
6/18/202112:30SEEKRoche wins FDA emergency use nod for COVID-19 PCR test
6/17/202108:02DJNSynlogic, Roche in Bowel-Disease Collaboration
See more news about this stock »
Your Recent History
USOTC
RHHBY
Roche (QX)
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211015 20:33:04